At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.

SAN DIEGO — It’s been decades since Vincent Rajkumar, a multiple myeloma physician and researcher at the Mayo Clinic, remembers first feeling that he was treating patients far too late.

Multiple myeloma and AL amyloidosis are conditions ... AL amyloidosis is more common in males than females. biopsy, to check for amyloid protein, which may take fat from the abdomen or tissue ...

In the study, a treatment combination including the drug, called Blenrep, cut the risk of death by 42% among patients with multiple myeloma, a result that was statistically significant and that He ...

So, with tissue testing, a lot of times we didn't have enough tissue to get things done, so liquid biopsy has made a huge difference. A lot of times when you don't have enough tissue or you can't ...

Myeloma specialist Dr. Urvi Shah is researching the role that whole-food and plant-based diets may play in slowing the progression of certain conditions into multiple myeloma. Many people who are ...

There’s no cure for multiple myeloma, but remission is possible with treatment. If your multiple myeloma treatment doesn’t work, there are many alternatives to improve your quality of life and ...

Liquid Biopsy can provide big-picture information regarding your cancer, as it collects pieces from cancer cells at multiple locations that come into contact with blood as opposed to one site from a ...

Liquid biopsy is an innovative new technology that tests cancer cells circulating in your bloodstream. It is not as sensitive a test as tumor-based next-generation sequencing (NGS) but it can be ...